Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.

Somalia, ravaged by conflict since 1991, has areas endemic for visceral leishmaniasis (VL), a deadly parasitic disease affecting the rural poor, internally displaced, and pastoralists. Very little is known about VL burden in Somalia, where the protracted crisis hampers access to health care. We revi...

Full description

Bibliographic Details
Main Authors: Temmy Sunyoto, Julien Potet, Marleen Boelaert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-03-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC5344316?pdf=render
id doaj-842a220dd8ac4a39a11aa7ae0a53b931
record_format Article
spelling doaj-842a220dd8ac4a39a11aa7ae0a53b9312020-11-25T00:02:09ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-03-01113e000523110.1371/journal.pntd.0005231Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.Temmy SunyotoJulien PotetMarleen BoelaertSomalia, ravaged by conflict since 1991, has areas endemic for visceral leishmaniasis (VL), a deadly parasitic disease affecting the rural poor, internally displaced, and pastoralists. Very little is known about VL burden in Somalia, where the protracted crisis hampers access to health care. We reviewed evidence about VL epidemiology in Somalia and appraised control options within the context of this fragile state's health system. VL has been reported in Somalia since 1934 and has persisted ever since in foci in the southern parts of the country. The only feasible VL control option is early diagnosis and treatment, currently mostly provided by nonstate actors. The availability of VL care in Somalia is limited and insufficient at best, both in coverage and quality. Precarious security remains a major obstacle to reach VL patients in the endemic areas, and the true VL burden and its impact remain unknown. Locally adjusted, innovative approaches in VL care provision should be explored, without undermining ongoing health system development in Somalia. Ensuring VL care is accessible is a moral imperative, and the limitations of the current VL diagnostic and treatment tools in Somalia and other endemic settings affected by conflict should be overcome.http://europepmc.org/articles/PMC5344316?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Temmy Sunyoto
Julien Potet
Marleen Boelaert
spellingShingle Temmy Sunyoto
Julien Potet
Marleen Boelaert
Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.
PLoS Neglected Tropical Diseases
author_facet Temmy Sunyoto
Julien Potet
Marleen Boelaert
author_sort Temmy Sunyoto
title Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.
title_short Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.
title_full Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.
title_fullStr Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.
title_full_unstemmed Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.
title_sort visceral leishmaniasis in somalia: a review of epidemiology and access to care.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2017-03-01
description Somalia, ravaged by conflict since 1991, has areas endemic for visceral leishmaniasis (VL), a deadly parasitic disease affecting the rural poor, internally displaced, and pastoralists. Very little is known about VL burden in Somalia, where the protracted crisis hampers access to health care. We reviewed evidence about VL epidemiology in Somalia and appraised control options within the context of this fragile state's health system. VL has been reported in Somalia since 1934 and has persisted ever since in foci in the southern parts of the country. The only feasible VL control option is early diagnosis and treatment, currently mostly provided by nonstate actors. The availability of VL care in Somalia is limited and insufficient at best, both in coverage and quality. Precarious security remains a major obstacle to reach VL patients in the endemic areas, and the true VL burden and its impact remain unknown. Locally adjusted, innovative approaches in VL care provision should be explored, without undermining ongoing health system development in Somalia. Ensuring VL care is accessible is a moral imperative, and the limitations of the current VL diagnostic and treatment tools in Somalia and other endemic settings affected by conflict should be overcome.
url http://europepmc.org/articles/PMC5344316?pdf=render
work_keys_str_mv AT temmysunyoto visceralleishmaniasisinsomaliaareviewofepidemiologyandaccesstocare
AT julienpotet visceralleishmaniasisinsomaliaareviewofepidemiologyandaccesstocare
AT marleenboelaert visceralleishmaniasisinsomaliaareviewofepidemiologyandaccesstocare
_version_ 1725439113856811008